Back

Lipoprotein(a) is associated with increased calcification and disease progression in aortic stenosis patients

28 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - New predictors of outcome in valve disease Aortic Valve Stenosis ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Kang He Zheng

Hospital Onze Lieve Vrouwe Gasthuis, Amsterdam (Netherlands (The))

13 More presentations in this session

Presentation thumbnail
Doctor M. Desai (Cleveland, US)
Abstract Slides
Presentation thumbnail
Doctor W. Avila Samuel (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Doctor D. Kohalmi (Bonyhad, HU)
Abstract Slides
Presentation thumbnail
Doctor G. Papadopoulos (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Doctor B. Mahon (Wellington, NZ)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - New predictors of outcome in valve disease

The Event

Event poster

ESC Congress 2018

28 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The potential role of elevated lipoprotein(a) in the early stages of aortic valve stenosis
31 August 2025
thumbnail
Webinar
Multi-modality imaging in aortic stenosis
28 April 2022
thumbnail
Congress Presentation
Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis
31 August 2025
thumbnail
Congress Presentation
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources